INVO BIOSCIENCE INC (INVO) Stock Analyst Ratings
USA - NASDAQ:INVO - US44984F4019 - Common Stock
0.833 USD
-0.03 (-2.91%)
0.825 USD
-0.01 (-0.96%)
ChartMill assigns a Buy % Consensus number of 43% to INVO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 20.4. This target is 2348.98% above the current price.
INVO was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about INVO.
In the previous month the buy percentage consensus was at a similar level.
INVO was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-04-13 | Roth Capital | Downgrade | Buy -> Neutral |
| 2022-01-19 | Maxim Group | Initiate | Buy |
| 2021-08-18 | Roth Capital | Maintains | Buy |
INVO BIOSCIENCE INC / INVO FAQ
Can you provide the average price target for INVO BIOSCIENCE INC stock?
6 analysts have analysed INVO and the average price target is 20.4 USD. This implies a price increase of 2348.98% is expected in the next year compared to the current price of 0.833.
Can you provide the consensus rating for INVO BIOSCIENCE INC stock?
The consensus rating for INVO BIOSCIENCE INC (INVO) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
How many analysts have analysed INVO BIOSCIENCE INC (INVO)?
The number of analysts covering INVO BIOSCIENCE INC (INVO) is 6.